Lilly launches diabetes and obesity access initiative
Eli Lilly (NYSE:LLY) launched the Change the Course Commitment, an initiative aimed at increasing access to its diabetes and obesity medicines in resource-limited settings before 2040.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Eli Lilly (NYSE:LLY) launched the Change the Course Commitment, an initiative aimed at increasing access to its diabetes and obesity medicines in resource-limited settings before 2040.
Kodiak Sciences (NASDAQ:KOD) reported that Zenkuda and tabirafusp-ted met primary vision endpoints in the Phase 3 DAYBREAK trial evaluating treatments for wet age-related macular degeneration.
Codexis (NASDAQ:CDXS) signed an agreement with an unnamed siRNA drug developer to explore stereo-defined fragment synthesis using its ECO Synthesis platform.
Bob Michele, global head of fixed income at JPMorgan Asset Management, expects the bond market to settle down after this week's US economic data and says, "if we see some stabilization here, we have our next buy level, we've got plenty of buying left to do." He speaks on "Bloomberg Surveillance."
National Healthcare Properties (NYSE:NHP) agreed to sell 40 outpatient medical facilities for approximately $531 million, with closing expected in the fourth quarter of 2026.
MediciNova (NASDAQ:MNOV) reported topline results from a Phase 2 placebo-controlled trial evaluating MN-001, also known as tipelukast, in patients with type 2 diabetes, fatty liver disease, and elevated triglycerides.
Gray Media (NYSE:GTN) raised its third-quarter 2026 political advertising revenue guidance to $188 million–$195 million, compared with its previous forecast of $165 million–$185 million.
Zymeworks (NASDAQ:ZYME) completed its acquisition of Theravance Biopharma for $17 per share, adding rights to YUPELRI profit sharing and international royalties.
Hudbay Minerals (NYSE:HBM) extended the reserve mine life of its Snow Lake operations in Manitoba to 2043 under an updated plan that increases projected gold production.
IDEAYA Biosciences (NASDAQ:IDYA) promoted Dr. Michael White from chief scientific officer to president of research and development, effective September 28, 2026.
Nvidia is rolling out two open-source software security tools designed to control what AI agents can access in real time and shut them down when they break the rules. The company says this would've prevented the recent high-profile breach of Hugging Face by OpenAI's artificial intelligence models. Neil Campling reports on Bloomberg Television.
U.S.-listed gold miners fell in premarket trading as spot gold prices declined 3.2% to $4,149.89 per ounce, reaching their lowest level since August 5.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade